Pubblicazioni ufficiali MedinCell S.A.

Azioni

Mercato chiuso - Euronext Paris Altri mercati azionari 17:35:20 06/05/2024			Variaz. 5gg	Var. 1 gen.
14,62 ^EUR	+2,24%		+15,48%	+103,06%

26/04	OPINIONI DEGLI ANALISTI : Saipem, Italgas, Credito Emiliano, Salcef Group, Hermes International, Befesa, Sika, Italgas, Hermes, Repsol, Nestlé...
16/04	Medincell stipula un accordo strategico di co-sviluppo e licenza con AbbVie per sviluppare terapie iniettabili a lunga durata d'azione di nuova generazione	CI

Half-year report	06/12/22	CO
1st-half-year results	06/12/22	CO
1st-half-year results	06/12/22	CO
Monthly statement on voting rights	30/11/22	CO
Business information	24/11/22	CO
Business information	24/11/22	CO
Monthly statement on voting rights	31/10/22	CO
Monthly statement on voting rights	30/09/22	CO
Monthly statement on voting rights	31/08/22	CO
Annual ESG Report	17/08/22	CO
Combined general shareholders meeting	01/08/22	CO
Monthly statement on voting rights	31/07/22	CO
Universal registration document	28/07/22	CO
Monthly statement on voting rights	30/06/22	CO
Slide show results	14/06/22	CO
Annual results	14/06/22	CO
Monthly statement on voting rights	31/05/22	CO
Changes in management and corporate officers	09/05/22	CO
Monthly statement on voting rights	30/04/22	CO
Annual ESG Report	31/03/22	CO
Monthly statement on voting rights	31/03/22	CO
Monthly statement on voting rights	28/02/22	CO
Monthly statement on voting rights	31/01/22	CO
Monthly statement on voting rights	31/12/21	CO
Slide show half-year results	08/12/21	CO